News Overview

Blackway Biosciences AG

Sina Kohlbrenner

Blackway Biosciences AG: provides preclinical drug discovery and development services across a spectrum of indications in the space of cardiometabolic and rare diseases, and across multiple modalities including small molecules, biologics and oligonucleotide therapeutics.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.